NCT02128074View on ClinicalTrials.gov

A Pilot Study of KRX-0502 (Ferric Citrate, Administered Without Food, in Treating Iron-deficiency Anemia

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Anemia of Chronic Kidney Disease
Interventions
DRUG

KRX-0502

1g tablets of KRX-0502

Trial Locations (3)

Unknown

Barzilai Medical Center, Ashkelon

Western Galilee Hospital, Nahariya

Nazareth Hospital- EMMS, Nazareth

Sponsors
All Listed Sponsors
lead

Keryx Biopharmaceuticals

INDUSTRY

NCT02128074 - A Pilot Study of KRX-0502 (Ferric Citrate, Administered Without Food, in Treating Iron-deficiency Anemia | Biotech Hunter | Biotech Hunter